AQR Capital Management’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$53.7M Sell
2,538,256
-40,795
-2% -$816K 0.02% 705
2025
Q4
$41.9M Sell
2,579,051
-147,941
-5% -$2.23M 0.02% 718
2025
Q3
$31.5M Sell
2,726,992
-1,410,809
-34% -$18.4M 0.02% 722
2025
Q2
$47.9M Buy
4,137,801
+2,925,372
+241% +$26.7M 0.04% 552
2025
Q1
$10.6M Buy
1,212,429
+695,227
+134% +$8.76M 0.01% 854
2024
Q4
$7.43M Sell
517,202
-211,830
-29% -$3.34M 0.01% 944
2024
Q3
$16.4M Buy
729,032
+413,852
+131% +$8.56M 0.02% 683
2024
Q2
$6.13M Buy
315,180
+219,945
+231% +$5.76M 0.01% 941
2024
Q1
$3.57M Buy
95,235
+46,710
+96% +$2.05M 0.01% 1137
2023
Q4
$2.72M Buy
48,525
+37,564
+343% +$1.63M 0.01% 1207
2023
Q3
$452K Sell
10,961
-2,850
-21% -$148K ﹤0.01% 1884
2023
Q2
$771K Buy
+13,811
New +$748K ﹤0.01% 1661
2021
Q2
Sell
-27,658
Closed -$4.91M 2301
2021
Q1
$4.91M Sell
27,658
-27,998
-50% -$4.83M 0.01% 831
2020
Q4
$7.88M Buy
+55,656
New +$8.08M 0.01% 670

Other funds holding TXG